Login / Signup

The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study.

Tommaso CaiLuca GallelliErika CioneGianpaolo PerlettiFrancesco CiarleglioGianni MalossiniGiovanni De PretisAlessandro PalmieriVincenzo MironeRiccardo BartolettiTruls E Bjerklund Johansen
Published in: World journal of urology (2021)
L. casei DG® prevents symptomatic recurrences and improves the quality of life in patients with CBP, reducing the antibiotic use.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • mouse model
  • prognostic factors